Gaining knowledge on rare diseases is limited by the scarcity and dispersity of patient data. Sequencing technologies have greatly contributed to elucidating the genetic components of these conditions, but a more comprehensive molecular picture remains to be uncovered. In this talk, we will discuss how digitalization can foster data collaboration and integrative analysis of multi-omics data across various diseases. We will show how to characterize rare disorders and build disease predictive models guiding the diagnosis and treatment of yet unknown conditions.
Subscribe to C-Path Now ►► https://www.youtube.com/c/CriticalPathInstitute
FOLLOW C-PATH: LinkedIn: https://www.linkedin.com/company/c-path
Facebook: https://www.facebook.com/CPathInstitute/
Twitter: https://twitter.com/CPathInstitute?re
ABOUT C-PATH:
Critical Path Institute (C-Path) is an independent, nonprofit organization established in 2005 as a public and private partnership. C-Path’s mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. An international leader in forming collaborations, C-Path has established numerous global consortia that currently include more than 1,600 scientists from government and regulatory agencies, academia, patient organizations, disease foundations, and hundreds of pharmaceutical and biotech companies. C-Path U.S. is headquartered in Tucson, Arizona, C-Path in Europe is headquartered in Amsterdam, Netherlands and C-Path Ltd. operates from Dublin, Ireland with additional staff in multiple other locations. For more information, visit c-path.org.
#CPath #datasharing #nonprofit #drugdevelopment #rdcadap #raredisease
Subscribe to C-Path Now ►► https://www.youtube.com/c/CriticalPathInstitute
FOLLOW C-PATH: LinkedIn: https://www.linkedin.com/company/c-path
Facebook: https://www.facebook.com/CPathInstitute/
Twitter: https://twitter.com/CPathInstitute?re
ABOUT C-PATH:
Critical Path Institute (C-Path) is an independent, nonprofit organization established in 2005 as a public and private partnership. C-Path’s mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. An international leader in forming collaborations, C-Path has established numerous global consortia that currently include more than 1,600 scientists from government and regulatory agencies, academia, patient organizations, disease foundations, and hundreds of pharmaceutical and biotech companies. C-Path U.S. is headquartered in Tucson, Arizona, C-Path in Europe is headquartered in Amsterdam, Netherlands and C-Path Ltd. operates from Dublin, Ireland with additional staff in multiple other locations. For more information, visit c-path.org.
#CPath #datasharing #nonprofit #drugdevelopment #rdcadap #raredisease
- Category
- Health
Be the first to comment